The Strategic Case for Outsourcing Cell Culture

The question isn’t simply whether an activity can be performed internally. It’s whether performing it internally is the best use of those resources.

Cell culture outsourcing is a good example. Growing and maintaining cells is essential to many research programs, but it is also labor-intensive and requires dedicated personnel, equipment, laboratory space, quality control, inventory management, and ongoing oversight.

For many research organizations, outsourcing some or all of these activities can provide a more efficient and flexible operating model—while allowing scientists to spend more of their time on the research activities that create the greatest value.

Highly trained scientists are one of the most valuable resources in any R&D organization.

Yet researchers can spend significant amounts of time on routine activities such as thawing cells, expanding cultures, replacing media, counting cells, checking viability, documenting processes, preparing aliquots, and managing cell inventories.

These activities are necessary. But they may not be the activities where an organization’s scientific talent creates the greatest competitive advantage.

Outsourcing routine cell culture activities allows internal scientists to devote more of their time to experimental design, data interpretation, assay development, target validation, drug screening, and other activities that directly advance research programs.

The objective isn’t simply to reduce work. It is to put the right work in the right hands.

Comparing internal and outsourced cell culture solely on the basis of the cost of growing a batch of cells can overlook much of the true cost of maintaining the capability internally.

A more complete analysis should consider the resources required across the entire operation.

Internal operations may require:

• Reagent and media procurement and inventory management
• Laboratory and equipment preparation
• Cell thawing and initial testing
• Multiple cycles of feeding, passage, and scale-up
• Cell counting and viability testing
• Documentation throughout the process
• QC sampling
• Harvesting, aliquoting, labeling, and controlled freezing
• Cleanup and equipment maintenance
• Management, training, troubleshooting, and supervision

There are also ongoing consumable costs associated with media, feed, vials, labels, storage boxes, liquid nitrogen, and other supplies.

Reliable cell culture also requires ongoing quality control.

Depending on the application, this can include batch-specific testing, Mycoplasma testing, cell line authentication, viability assessment, environmental monitoring, equipment checks, documentation, and other QC activities.

Organizations must therefore consider not only the cost of performing the culture itself, but also the infrastructure and expertise required to consistently produce cells that meet research specifications.

Cell banks and research inventories must be stored, tracked, retrieved, and maintained over time.

That requires:

• Freezer and liquid nitrogen storage capacity
• Inventory management systems
• Personnel to manage and retrieve samples
• Backup and monitoring systems
• Procedures to reduce the risk of lost, misplaced, or compromised samples

These activities may receive relatively little attention when organizations evaluate the cost of maintaining cell culture internally, but they are an important part of the overall operation.

An internal cell culture operation can also require substantial dedicated infrastructure, including:

• Incubators
• Freezers and refrigerators
• Laminar flow or biosafety hoods
• Water baths
• Cell counters
• Centrifuges
• Liquid nitrogen tanks
• Other analytical and QC equipment

In addition to the initial investment, organizations must account for laboratory space, maintenance, calibration, monitoring, repairs, and eventual equipment replacement.

Cell culture carries operational risks as well.

Contamination can compromise an entire batch and potentially affect downstream experiments. Equipment failures can interrupt workflows or jeopardize valuable cell banks. Personnel turnover can create knowledge gaps and require additional training.

A specialized cell culture partner can help distribute these risks by providing established infrastructure, trained personnel, standardized processes, quality systems, and redundant capabilities.

One of the most important advantages of outsourcing is flexibility.

Research needs rarely remain constant. Programs begin and end. Screening activity increases. New projects enter the pipeline. A large batch may suddenly be required for an important study.

Maintaining enough internal staff and infrastructure to accommodate peak demand can leave resources underutilized during quieter periods.

An outsourcing partner provides another option: access additional capacity when it is needed without permanently expanding internal headcount, equipment, or laboratory space.

This can allow research organizations to:

• Scale cell production as program requirements change
• Run multiple projects simultaneously
• Adjust batch timing based on experimental needs
• Access additional capacity without lengthy hiring or equipment purchases
• Reduce bottlenecks when internal laboratories are operating at capacity

Outsourcing therefore becomes more than a cost decision. It can be an important component of a flexible R&D operating model.

Perhaps the most important cost is also the hardest to see: what could your scientists be doing instead?

Every hour a researcher spends growing cells, managing inventory, troubleshooting equipment, or performing routine preparation is an hour that cannot be spent designing experiments, analyzing results, investigating unexpected findings, or advancing promising therapeutic programs.

For activities that are necessary but not strategically differentiating, outsourcing can create leverage by shifting routine execution to a partner that performs those activities as a core competency.

The right question is therefore not:

“Should we outsource cell culture?”

It is:

“Which activities should our internal scientists perform, and which can be performed more efficiently by a specialized partner?”

That distinction can help organizations build an R&D model that is more focused, scalable, and efficient.

In some cases, even this can be treated as a relief-valve: When a trusted partner is in place to handle key functions, you can use them (or not) as your own team’s workload fluctuates.

ABS Bio has more than three decades of experience providing custom biological reagents and laboratory services to research organizations.

Our cell culture and related capabilities include:

• Ready-to-use cells
• Cell expansion and scale-up
• Cell banking and cryostorage
• Cell line identification and quality control
• DNA and RNA extraction
• Protein extraction
• Transfection
• Cell sorting
• Flow cytometry, cell QC, and phenotyping
• Custom cell and tissue preparations

Because these activities are part of our core operations, ABS Bio can provide specialized expertise and infrastructure without requiring clients to build and maintain the same capacity internally.

We work as an extension of your laboratory—providing support when and where you need it while allowing you to retain control over which capabilities remain in-house.

Cell culture is essential to drug discovery. But that doesn’t necessarily mean every cell culture activity needs to be performed by your internal research team.

Well-run R&D organizations continually evaluate where their people, facilities, and capital can generate the greatest return.

For many, outsourcing routine and resource-intensive laboratory activities is one way to create additional capacity, improve operating flexibility, and keep scientists focused on what they do best: research and discovery.